7.0M
XNAS Volume
High vol. this week
XNAS 04 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Ryan M. Confer | Director, President, CEO and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 18 Feb 2025 | 395 | 38,743 (0%) | 0% | 0.4 | 162 | Common Stock |
| Mark S. Berger | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 18 Feb 2025 | 585 | 22,471 (0%) | 0% | 0.4 | 240 | Common Stock |
| Ryan M. Confer | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 29,375 | 39,138 (0%) | 0% | 0 | Common Stock | |
| William Wilson R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 4,750 | 7,845 (0%) | 0% | 0 | Common Stock | |
| Mark S. Berger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 18,250 | 23,056 (0%) | 0% | 0 | Common Stock | |
| Jose Antonio Moreno Toscano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 4,750 | 7,845 (0%) | 0% | 0 | Common Stock | |
| S. Mark Berger | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.40 per share. | 18 Feb 2024 | 1,319 | 4,806 (0%) | 0% | 4.4 | 5,804 | Common Stock |
| J. Rodney Varner | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.40 per share. | 18 Feb 2024 | 2,642 | 26,352 (0%) | 0% | 4.4 | 11,625 | Common Stock |
| M. Confer Ryan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.40 per share. | 18 Feb 2024 | 1,126 | 9,763 (0%) | 0% | 4.4 | 4,954 | Common Stock |
| Toscano Jose Antonio Moreno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 123,795 | 123,795 (0%) | 0% | 0 | Common Stock | |
| William R. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 123,795 | 123,795 (0%) | 0% | 0 | Common Stock | |
| Catherine M. Vaczy | EVP GC Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 21 Apr 2023 | 20,000 | 265,000 (0%) | 0% | 1.1 | 21,478 | Common Stock |
| J. Rodney Varner | Director, Chairman, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 21 Apr 2023 | 19,000 | 20,800 (0%) | 0% | 1.1 | 20,045 | Common Stock |
| Hemant Kumar | Chief Mfgr & Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 200,000 | 200,000 (0%) | 0% | 0 | Common Stock | |
| Catherine M. Vaczy | EVP GC Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 245,000 | 245,000 (0%) | 0% | 0 | Common Stock | |
| Mark S. Berger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 245,000 | 245,000 (0%) | 0% | 0 | Common Stock | |
| J. Rodney Varner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 625,000 | 1,159,735 (3%) | 1% | 0 | Common Stock | |
| Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 245,000 | 435,499 (1%) | 0% | 0 | Common Stock | |
| Ryan M. Confer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.02 per share. | 28 Jul 2022 | 116,973 | 190,499 (0%) | 0% | 0.0 | 1,755 | Common Stock |
| Ryan M. Confer | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2022 | 116,973 | 0 | - | - | Stock Option (right to buy) | |
| Hemant Kumar | Chief Mfgr & Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Toscano Jose Antonio Moreno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 83,368 | 83,368 | - | - | Stock Option (right to buy) | |
| William R. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 83,368 | 83,368 | - | - | Stock Option (right to buy) | |
| Hemant Kumar | Chief Mfgr & Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 54,312 | 54,312 | - | - | Stock Option (right to buy) | |
| Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 341,750 | 341,750 | - | - | Stock Option (right to buy) | |
| J. Rodney Varner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 1,062,250 | 1,062,250 | - | - | Stock Option (right to buy) | |
| Mark S. Berger | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 98,750 | 98,750 | - | - | Stock Option (right to buy) | |
| Catherine M. Vaczy | EVP GC Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 325,000 | 325,000 | - | - | Stock Option (right to buy) | |
| Hemant Kumar | Chief Mfgr & Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2021 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Toscano Jose Antonio Moreno | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 32,376 | 32,376 | - | - | Stock Option (right to buy) | |
| William R. Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 32,376 | 32,376 | - | - | Stock Option (right to buy) | |
| Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 235,000 | 235,000 | - | - | Stock Option (right to buy) | |
| J. Rodney Varner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 460,000 | 460,000 | - | - | Stock Option (right to buy) | |
| Michael T Redman | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Catherine M. Vaczy | EVP GC Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| J. Rodney Varner | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2020 | 530,000 | 530,000 | - | - | Stock Option (right to buy) | |
| Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2020 | 270,000 | 270,000 | - | - | Stock Option (right to buy) | |
| Toscano Jose Antonio Moreno | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2020 | 42,068 | 42,068 | - | - | Stock Option (right to buy) | |
| William R. Wilson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2020 | 42,068 | 42,068 | - | - | Stock Option (right to buy) | |
| David E. Friedman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 68,376 | 68,376 | - | - | Stock Option (Right to Buy) | |
| Robert Pearson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2019 | 68,376 | 68,376 | - | - | Stock Option (Right to Buy) | |
| J. Rodney Varner | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 05 Sep 2019 | 1,800 | 1,800 (0%) | 0% | 0.9 | 1,595 | Common Stock |
| Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2019 | 230,769 | 230,769 | - | - | Stock Option (Right to Buy) | |
| Julien L. Pham | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2019 | 432,692 | 432,692 | - | - | Stock Option (Right to Buy) | |
| J. Rodney Varner | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2019 | 615,384 | 615,384 | - | - | Stock Option (Right to Buy) | |
| Robert Pearson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2018 | 101,156 | 101,156 | - | - | Stock Option (Right to Buy) | |
| David E. Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2018 | 101,156 | 101,156 | - | - | Stock Option (Right to Buy) | |
| David E. Friedman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2018 | 101,156 | 101,156 | - | - | Stock Option (Right to Buy) | |
| J. Rodney Varner | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2018 | 551,284 | 551,284 | - | - | Stock Option (Right to Buy) | |
| Robert Pearson | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2018 | 101,156 | 101,156 | - | - | Stock Option (Right to Buy) | |
| Julien L. Pham | President & COO | Purchase of securities on an exchange or from another person at price $ 3.40 per share. | 30 Jul 2018 | 500 | 500 (0%) | 0% | 3.4 | 1,700 | Common Stock |
| Ryan M. Confer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 327,236 | 327,236 | - | - | Stock option (right to buy) | |
| Julien L. Pham | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2018 | 659,346 | 659,346 | - | - | Stock option (right to buy) | |
| J. Rodney Varner | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 29 Mar 2018 | 10,000 | 544,735 (4%) | 0% | 5 | 50,000 | Common Stock |